Gainers
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) jumped 125.3% to close at $18.77 on Tuesday after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy adult volunteers.
Gainers
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) climbed 79.3% to $14.93 after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy adult volunteers.
Shares of The RealReal (NASDAQ:REAL) decreased in after-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share were down 19.05% year over year to ($0.50), which missed the estimate of ($0.47).
The RealReal (NASDAQ:REAL) reported quarterly losses of $(0.50) per share which missed the analyst consensus estimate of $(0.47) by 6.38 percent. This is a 19.05 percent decrease over losses of $(0.42) per share from the
Companies Reporting Before The Bell
• Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million.